Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desferal to improve hypoxic response in type 1 diabetes (DESIRED)
2016-003621-41Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of deferoxamine in diabetes mellitus type 1 (T1D), sponsored by Karolinska University Hospital. Primary endpoint: Endothelial progenitor cell number increase after intermittent hypoxia exposure. Started Sep 2016; status: active.
02
Drugs
deferoxamine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2016-003621-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003621-41.